Viewing Study NCT05667493


Ignite Creation Date: 2025-12-25 @ 1:24 AM
Ignite Modification Date: 2025-12-27 @ 5:10 AM
Study NCT ID: NCT05667493
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2025-12-12
First Post: 2022-07-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
Sponsor: Ionis Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module